Variant report
Variant | esv3521946 |
---|---|
Chromosome Location | chr12:72724435-72726333 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551546111 | chr12:72724452-72724453 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563482878 | chr12:72724497-72724498 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144843113 | chr12:72724506-72724507 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567344082 | chr12:72724652-72724653 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35786617 | chr12:72724737-72724738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187545574 | chr12:72724739-72724740 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567272353 | chr12:72724778-72724779 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534548441 | chr12:72724794-72724795 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138762547 | chr12:72724875-72724876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571354490 | chr12:72724885-72724886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555238598 | chr12:72724904-72724905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs61926576 | chr12:72724950-72724951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4760761 | chr12:72724957-72724958 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs192125015 | chr12:72724980-72724981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7955732 | chr12:72724995-72724996 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs377050252 | chr12:72725075-72725076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140234448 | chr12:72725076-72725077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376301748 | chr12:72725095-72725096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185747227 | chr12:72725120-72725121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs386764163 | chr12:72725141-72725142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11834123 | chr12:72725150-72725151 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs577692195 | chr12:72725164-72725165 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544919717 | chr12:72725187-72725188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145288566 | chr12:72725252-72725253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78787388 | chr12:72725253-72725254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542932518 | chr12:72725300-72725301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs386508312 | chr12:72725309-72725310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561134396 | chr12:72725332-72725333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528129625 | chr12:72725344-72725345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369642920 | chr12:72725365-72725366 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201508581 | chr12:72725369-72725370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546599348 | chr12:72725476-72725477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7135395 | chr12:72725546-72725547 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs532236317 | chr12:72725570-72725571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368741586 | chr12:72725591-72725592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190557583 | chr12:72725652-72725653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34097668 | chr12:72725802-72725803 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs556040013 | chr12:72725803-72725804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35124993 | chr12:72725829-72725830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567602901 | chr12:72725916-72725917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34965504 | chr12:72725927-72725928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534723706 | chr12:72725982-72725983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192466739 | chr12:72725987-72725988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575078934 | chr12:72725992-72725993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs113360460 | chr12:72725998-72725999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577754000 | chr12:72726011-72726012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545491300 | chr12:72726023-72726024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12819989 | chr12:72726064-72726065 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs540975587 | chr12:72726065-72726066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs35700010 | chr12:72726114-72726115 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16620391 | CNVD |
Disease | 21505450 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 20685689 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Cancer | 20164920 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:72713400-72738400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr12:72723600-72725000 | Enhancers | Psoas Muscle | Psoas |
3 | chr12:72723600-72725400 | Enhancers | Fetal Kidney | kidney |
4 | chr12:72723800-72724600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr12:72723800-72724800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr12:72724200-72724600 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr12:72724200-72724600 | Active TSS | Stomach Smooth Muscle | stomach |
8 | chr12:72724200-72724800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr12:72724400-72724600 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr12:72724400-72724800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr12:72724400-72724800 | Enhancers | Ovary | ovary |
12 | chr12:72724400-72728200 | Weak transcription | Adipose Nuclei | Adipose |
13 | chr12:72724400-72728600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
14 | chr12:72724400-72728600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
15 | chr12:72724400-72730400 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
16 | chr12:72724800-72730400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
17 | chr12:72725000-72725400 | Weak transcription | Psoas Muscle | Psoas |
18 | chr12:72725400-72725600 | Enhancers | Psoas Muscle | Psoas |
19 | chr12:72725600-72730400 | Weak transcription | Psoas Muscle | Psoas |